Article
Plasminogen activator inhibitor-1 4G/5G genetic polymorphism does not affect peritoneal transport characteristic.
American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 May 2002
Szeto Cheuk-Chun, Poon Peter, Szeto Carol Yi-Ki, Wong Teresa Yuk-Hwa, Lai Ka-Bik, Li Philip Kam-Tao
Abstract excerpt
There is evidence that type 1 plasminogen activator inhibitor (PAI-1) may have an important role in peritoneal function. We studied the effect of physiologically relevant PAI-1 promotor polymorphisms on peritoneal permeability. We performed a standard peritoneal equilibration test (PET) in 100 new continuous ambulatory peritoneal dialysis (CAPD) patients. We studied another 48 prevalent CAPD patients who had a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.